Norwich, United Kingdom

Meng Wang


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meng Wang: Innovator in Activation-Induced Cytidine Deaminase Research

Introduction

Meng Wang is a prominent inventor based in Norwich, GB. He has made significant contributions to the field of molecular biology, particularly through his innovative work on activation-induced cytidine deaminase (AID) proteins. His research focuses on enhancing the functionality of these proteins, which play a crucial role in the immune response.

Latest Patents

Meng Wang holds a patent for "Mutants of activation-induced cytidine deaminase (AID) and methods of use." This invention provides functional mutants of the AID protein that exhibit increased activity compared to the wild-type AID protein. The patent also includes nucleic acids encoding these functional AID mutants, as well as vectors and cells that incorporate these nucleic acids. Furthermore, it outlines methods for utilizing the functional mutant AID proteins in various applications.

Career Highlights

Meng Wang is affiliated with the Medical Research Council, where he conducts his research. His work has garnered attention for its potential applications in therapeutic settings, particularly in enhancing immune responses. With a focus on innovative solutions, he continues to push the boundaries of what is possible in his field.

Collaborations

Meng Wang collaborates with esteemed colleagues, including Zizhen Yang and Cristina Rada. These partnerships enhance the research environment and contribute to the advancement of knowledge in molecular biology.

Conclusion

Meng Wang's contributions to the field of activation-induced cytidine deaminase research exemplify the impact of innovative thinking in science. His patented work not only advances our understanding of AID proteins but also opens new avenues for therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…